BioSpace News Archive

Feb. 20, 2020 13:30 UTC -- Additional data from Phase 2 study show that MGTA-456 demonstrates clinically meaningful durable benefits for patients with inherited metabolic disorders one year following treatment – -- Magenta intends to complete enrollment in Phase 2 in 2020 and continue dialogue with the FDA under the RMAT designation on design of a registration-enabling study, and to have discussions with the European Medicines Agency for development in Europe as well –

DentalXChange, creator of industry-leading electronic claims solution, ClaimConnect, has announced the completion of two new contracts with Delta Dental payer networks, expanding its DDS Enroll credentialing software platform to a total of six states nationwide.

BEDFORD, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today participation and presentations at the following investor and scientific conferences: BTIG Targeted Therapeutics Conference at The St. Regis New York Panel presentation, “Gene Therapy: How Do You Build More Than a One-Stop-Shop to Derive Value?”: February 24 at 10:00 a.m. ET Cowen 40th Annual Healthcare Conference at Boston Marriott Copley Place C

Cancer Genetics, Inc. (Nasdaq: CGIX) (“Cancer Genetics” or the “Company”), a leader in drug discovery and preclinical oncology and immuno-oncology services, today published a letter to shareholders from its Chief Executive Officer, Jay Roberts.

Signals Analytics, the next-generation advanced analytics platform that leverages external data to uncover trends and predictive insights, today announces the addition of 1,600 rare diseases, deepening its already extensive coverage of medical conditions and therapeutic areas

Supplemental funding from the Bill & Melinda Gates Foundation supports study of Biological Dynamics’ novel TB detection test performance using clinical samples

Guidelines for over-the-counter hearing aids, expected this year from the Food and Drug Administration, will make the devices much more accessible to the general public, but how prepared are people to make good choices?

Inc. magazine revealed that Limelight Health is No. 64 on its inaugural Inc. 5000 Series: California list, the most prestigious ranking of the fastest-growing California-based private companies.

Aya Healthcare, the company transforming travel nurse staffing and healthcare workforce solutions across the United States, is honored to announce that six winners have been selected in the company’s second annual Future Travel Nurse Scholarship program.

The nation’s largest general veterinary practice and its charitable arm positively impacted the lives of millions of pets and people last year through volunteer efforts, free veterinary care and more